Projects per year
19/04/19 → 18/04/24
Multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of Fulvestrant (Faslodex) with or without pd-0332991 (Palbociclib) +/- Goserelin in women with hormone receptor-positive, HER2-negative metastatic breast cancer whose disease progressed after prior endocrine therapy
29/03/19 → 28/03/24
Research Output per year
How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancerTFGT Collaborative Group, 28 Jul 2012, In : BMC Cancer. 12, 320.
Research output: Contribution to journal › Article › Other › peer-review
Sentinel node micrometastases in breast cancer: A survey of Australian and New Zealand breast surgeonsChong, C. Y. L., Mirbagheri, N., Harris, M. & Fox, J., Nov 2012, In : ANZ Journal of Surgery. 82, 11, p. 766-767 2 p.
Research output: Contribution to journal › Comment / Debate › Other › peer-review